← Back to directory
KP
Kurma Partners
Paris, FranceWebsite ↗
Kurma Partners is a European venture capital firm established in 2009, based in Paris, France. It specializes in healthcare and biotechnology, focusing on early-stage investments to develop disruptive therapeutic solutions and medical innovations for severe or incurable diseases.
Last raised
Apr 2026
5 mo ago
Latest fund size
$252M
Biofund IV
AUM
$1.1B
estimated
Funds raised
Capital this firm has raised, newest first
Kurma Biofund II
Unknown
—
Kurma Biofund I
Unknown
—
Biofund IV
Apr 2026
$252M
Kurma Growth Opportunities
Jan 2024
—
Kurma Diagnostics II
Jan 2021
—
Kurma Biofund III
Jan 2018
$186M
Paris Saclay Seed Fund
Jan 2017
—
Kurma Diagnostics
Jan 2015
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Nuclidium | Growth | — | May 2026 | |
| Tacalyx | — | — | Apr 2026 | |
| Memo Therapeutics | — | — | Apr 2026 | |
| SciRhom | — | — | Apr 2026 | |
| Laigo Bio | Seed | $636M | Mar 2026 | |
| Alveus Therapeutics | Series A | $197M | Mar 2026 | |
| AdcytherixLead | Series A | — | Oct 2025 | |
| Adaptam Therapeutics | Seed | $3M | Oct 2025 |
Sources
Where this data came from